Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

KalVista reports $49.1M in EKTERLY revenue as commercial pivot drives strategic transition

KalVista Pharmaceuticals (NASDAQ:KALV) today reported financial results for the abbreviated fiscal period ended December 31, 2025, marking the company’s formal transition from a clinical-stage developer to a commercial-stage biopharmaceutical entity.

Leia mais: KalVista reports $49.1M in EKTERLY revenue as commercial pivot drives strategic transition
Grafa
Defence

Lockheed Martin and Department of War to quadruple PrSM production following combat debut

Lockheed Martin (NYSE:LMT) and the U.S. Department of War (DoW) announced a landmark framework agreement on March 25, 2026, to dramatically accelerate the manufacturing of Precision Strike Missiles (PrSM).

Leia mais: Lockheed Martin and Department of War to quadruple PrSM production following combat debut
Grafa

Kiora Pharmaceuticals secures long-term cash runway as dual retinal trials advance

Kiora Pharmaceuticals (NASDAQ:KPRX) released its fourth-quarter and full-year 2025 financial results on Wednesday, detailing a streamlined balance sheet and steady clinical momentum for its pipeline of retinal disease treatments.

Leia mais: Kiora Pharmaceuticals secures long-term cash runway as dual retinal trials advance
Grafa
Technology

Honeywell secures $500M framework deal with U.S. Department of War to scale defense production

Honeywell Aerospace (NASDAQ:HON) entered into a landmark supplier framework agreement with the U.S. Department of War on March 25, 2026, marking a significant escalation in the company’s defense manufacturing footprint.

Leia mais: Honeywell secures $500M framework deal with U.S. Department of War to scale defense production